DEREK CHALMERS, PH.D., D.SC.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cara Therapeutics, Inc.

Filing Date Source Excerpt
2015-04-24 Dr. Chalmers holds a D.Sc. and Ph.D. in Pharmacology from the University of Glasgow. His qualifications include leadership, executive, managerial and business experience in biotechnology.
2016-04-27 Dr. Chalmers holds a D.Sc. and Ph.D. in Pharmacology from the University of Glasgow. Dr. Chalmers’ qualifications include his leadership, executive, managerial and business experience, historical knowledge of our company and his background and experience in the biotechnology industry.
2017-05-10 Dr. Chalmers holds a D.Sc. and Ph.D. in Pharmacology from the University of Glasgow. Dr. Chalmers’ qualifications to sit on our Board of Directors include his leadership, executive, managerial and business experience, historical knowledge of our company and his background and experience in the biotechnology industry, including having been a founder of a prior biotechnology company.
2018-04-26 Dr. Chalmers holds a D.Sc. and Ph.D. in Pharmacology from the University of Glasgow. Dr. Chalmers' qualifications to sit on our Board of Directors include his leadership, executive, managerial and business experience, historical knowledge of our company and his background and experience in the biotechnology industry.
2019-04-24 Dr. Chalmers holds a D.Sc. and Ph.D. in Pharmacology from the University of Glasgow. Dr. Chalmers’ qualifications to sit on the Board include his leadership, executive, managerial and business experience, historical knowledge of our company and his background and experience in the biotechnology industry.
2020-04-22 Dr. Chalmers holds a D.Sc. and Ph.D. in Pharmacology from the University of Glasgow. Dr. Chalmers’ qualifications to sit on the Board include his leadership, executive, managerial and business experience, historical knowledge of our company and his background and experience in the biotechnology industry.
2021-04-23 Dr. Chalmers holds a D.Sc. and Ph.D. in Pharmacology from the University of Glasgow. Dr. Chalmers’ qualifications to sit on the Board include his leadership, executive, managerial and business experience, historical knowledge of our company and his background and experience in the biotechnology industry.

Data sourced from SEC filings. Last updated: 2026-03-09